Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD)
The summary for the Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.
Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD): The purpose of this Notice of Funding Opportunity is to enable the continuation of the active, nationwide study, begun in 1995, of recipients of blood products from donors who are subsequently diagnosed with classic forms of Creutzfeldt-Jakob Disease (CJD) in order to assess the risk of possible transmission of such forms of CJD by blood transfusion.
Federal Grant Title: | Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD) |
Federal Agency Name: | Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-CK-19-004 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.084 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | March 19th, 2019 |
Original Application Deadline: | March 19th, 2019 |
Posted Date: | November 28th, 2018 |
Creation Date: | November 28th, 2018 |
Archive Date: | April 18th, 2019 |
Total Program Funding: | $385,000 |
Maximum Federal Grant Award: | $77,000 |
Minimum Federal Grant Award: | $70,000 |
Expected Number of Awards: | 1 |
Cost Sharing or Matching: | No |
Last Updated: | November 28th, 2018 |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Single Source Competition: Eligibility Limited to the American Red Cross
- Grant Announcement Contact
- Deborah Loveys
[email protected]
Grants Policy - Similar Government Grants
- • NCHHSTP Epidemiologic and Economic Modeling for HIV, Viral Hepatitis, STD, and TB
- • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...
- • Improving the Quality of Life of People with HIV Aged 50 Years and Older in the United Sta...
- • Understanding Infant Feeding Preferences, Practices, and Outcomes for Mothers and other Pa...
- • PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Rese...
- • Impact of Japanese Encephalitis Vaccination in Cambodia
- • Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monk...
- • Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic C...
- More Grants from the Centers for Disease Control and Prevention ERA
- • Collaborative research on influenza and other respiratory pathogens in South Africa
- • Advancing Public Health Research in Bangladesh
- • Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works i...
- • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...
- • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...